First Header Logo Second Header Logo

Connection

Steven Feldman to Methotrexate

Back to Details
This is a "connection" page, showing publications Steven Feldman has written about Methotrexate.
Steven Feldman
Connection Strength
4.982
Methotrexate
  1. Farhangian ME, Feldman SR. Immunogenicity of biologic treatments for psoriasis: therapeutic consequences and the potential value of concomitant methotrexate. Am J Clin Dermatol. 2015 Aug; 16(4):285-294.
    View in: PubMed
    Score: 0.496
  2. Feldman SR. Psoriasis: the new and the old. J Drugs Dermatol. 2014 Aug; 13(8):894.
    View in: PubMed
    Score: 0.463
  3. Davis SA, Krowchuk DP, Feldman SR. Prescriptions for a toxic combination: use of methotrexate plus trimethoprim-sulfamethoxazole in the United States. South Med J. 2014 May; 107(5):292-3.
    View in: PubMed
    Score: 0.455
  4. Zargari O, Hejazi S, Shahidi-Dadras M, Younespour S, Robati R, Firooz A, Toosi P, Feldman SR. Considerable variation among Iranian dermatologists in the dosing and monitoring of methotrexate for treating psoriasis. Int J Dermatol. 2014 Mar; 53(3):385-9.
    View in: PubMed
    Score: 0.439
  5. Al-Dabagh A, Davis SA, Kinney MA, Huang K, Feldman SR. The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA. Am J Clin Dermatol. 2013 Jun; 14(3):155-61.
    View in: PubMed
    Score: 0.427
  6. Davis SA, Feldman SR. Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials. JAMA Dermatol. 2013 Apr; 149(4):490-1.
    View in: PubMed
    Score: 0.422
  7. Searles AD, Lee AD, Feldman SR. Is concomitant use of methotrexate and oral retinoids dangerous? A review of the data regarding this combination. J Am Acad Dermatol. 2011 Apr; 64(4):791-3.
    View in: PubMed
    Score: 0.368
  8. Lucas J, Ntuen E, Pearce DJ, Fleischer AB, Feldman SR. Methotrexate: understanding the risk in psoriasis patients. J Dermatolog Treat. 2009; 20(5):311-3.
    View in: PubMed
    Score: 0.315
  9. Wilson JK, Phelps KC, Feldman SR. Use of transcutaneous nerve stimulation wristband to treat methotrexate-induced nausea. J Cutan Med Surg. 2002 Nov-Dec; 6(6):551-3.
    View in: PubMed
    Score: 0.205
  10. Yousaf A, Gayam S, Feldman S, Zinn Z, Kolodney M. Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study. J Am Acad Dermatol. 2021 01; 84(1):70-75.
    View in: PubMed
    Score: 0.177
  11. Cuellar-Barboza A, Bashyam AM, Ghamrawi RI, Aickara D, Feldman SR, Pichardo RO. Methotrexate for the treatment of recalcitrant genital and extragenital lichen sclerosus: A retrospective series. Dermatol Ther. 2020 07; 33(4):e13473.
    View in: PubMed
    Score: 0.174
  12. Smith J, Cline A, Feldman SR. Advances in Psoriasis. South Med J. 2017 01; 110(1):65-75.
    View in: PubMed
    Score: 0.137
  13. Faulks SW, Feldman SR. Presenting treatment safety data: subjective interpretations of objective information. Cutis. 2016 Oct; 98(4):259-262.
    View in: PubMed
    Score: 0.135
  14. Davis SA, Feldman SR. Combination therapy for psoriasis in the United States. J Drugs Dermatol. 2013 May; 12(5):546-50.
    View in: PubMed
    Score: 0.106
  15. Lapolla W, Yentzer BA, Bagel J, Halvorson CR, Feldman SR. A review of phototherapy protocols for psoriasis treatment. J Am Acad Dermatol. 2011 May; 64(5):936-49.
    View in: PubMed
    Score: 0.092
  16. Strowd LC, Yentzer BA, Fleischer AB, Feldman SR. Increasing use of more potent treatments for psoriasis. J Am Acad Dermatol. 2009 Mar; 60(3):478-81.
    View in: PubMed
    Score: 0.078
  17. Pearce DJ, Stealey KH, Balkrishnan R, Fleischer AB, Feldman SR. Psoriasis treatment in the United States at the end of the 20th century. Int J Dermatol. 2006 Apr; 45(4):370-4.
    View in: PubMed
    Score: 0.065
  18. Pearce DJ, Higgins KB, Stealey KH, Balkrishnan R, Crane MM, Camacho F, Fleischer AB, Feldman SR. Adverse events from systemic therapies for psoriasis are common in clinical practice. J Dermatolog Treat. 2006; 17(5):288-93.
    View in: PubMed
    Score: 0.064
  19. Feldman SR, Nijsten T, Margolis DJ, Rolstad T. Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing. J Am Acad Dermatol. 2005 Jan; 52(1):140-1.
    View in: PubMed
    Score: 0.060
  20. Lebwohl M, Menter A, Koo J, Feldman SR. Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol. 2004 Mar; 50(3):416-30.
    View in: PubMed
    Score: 0.056
  21. Menter MA, Krueger GC, Feldman SR, Weinstein GD. Psoriasis treatment 2003 at the new millennium: position paper on behalf of the authors. J Am Acad Dermatol. 2003 Aug; 49(2 Suppl):S39-43.
    View in: PubMed
    Score: 0.054
  22. Lebwohl M, Menter A, Koo J, Feldman S. Case studies in severe psoriasis: A clinical strategy. J Dermatolog Treat. 2003; 14 Suppl 2:26-46.
    View in: PubMed
    Score: 0.052
  23. Clowse ME, Feldman SR, Isaacs JD, Kimball AB, Strand V, Warren RB, Xibillé D, Chen Y, Frazier D, Geier J, Proulx J, Marren A. Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis. Drug Saf. 2016 08; 39(8):755-62.
    View in: PubMed
    Score: 0.033
  24. Shaw MK, Davis SA, Feldman SR, Fleischer AB. Trends in systemic psoriasis treatment therapies from 1993 through 2010. J Drugs Dermatol. 2014 Aug; 13(8):917-20.
    View in: PubMed
    Score: 0.029
  25. Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN, Chamlin SL, Cooper KD, Feldman SR, Hanifin JM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Silverman RA, Simpson EL, Tom WL, Williams HC, Elmets CA, Block J, Harrod CG, Begolka WS, Eichenfield LF. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014 Aug; 71(2):327-49.
    View in: PubMed
    Score: 0.028
  26. Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JY, Elmets CA, Korman NJ, Beutner KR, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008 May; 58(5):826-50.
    View in: PubMed
    Score: 0.019
  27. Gottlieb A, Korman NJ, Gordon KB, Feldman SR, Lebwohl M, Koo JY, Van Voorhees AS, Elmets CA, Leonardi CL, Beutner KR, Bhushan R, Menter A. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008 May; 58(5):851-64.
    View in: PubMed
    Score: 0.019
  28. Nijsten T, Margolis DJ, Feldman SR, Rolstad T, Stern RS. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. J Am Acad Dermatol. 2005 Mar; 52(3 Pt 1):434-44.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.